Cronos Group Inc (CRON) is near the top in its industry group according to InvestorsObserver. CRON gets an overall rating of 31. That means it scores higher than 31 percent of stocks. Cronos Group Inc gets a 62 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 145 out of 148 industries.
Click Here to get the full Stock Score Report on Cronos Group Inc (CRON) Stock.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 31 means the stock is more attractive than 31 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Cronos Group Inc Stock Today?
Cronos Group Inc (CRON) stock is trading at $7.13 as of 9:51 AM on Tuesday, Jan 14, a decline of -$0.38, or -5.06% from the previous closing price of $7.51. The stock has traded between $7.08 and $7.68 so far today. Volume today is below average. So far 1,149,531 shares have traded compared to average volume of 7,448,931 shares.
To see the top 5 stocks in Drug Manufacturers - Specialty & Generic click here.
